Karen Wagener

Dr. Karen Wagener

Clinical Unit for Herd Health Management in Ruminants, University Clinic for Ruminants, University of Veterinary Medicine Vienna
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Theriogenology
Verified
Journal Article
Closed access
Karen WagenerKaren Wagener
Karen Wagener
CGChristoph Gabler
Christoph Gabler
MDMarc Drillich
Marc Drillich


1 December 2014 in Theriogenology
Verified
Journal Article
Closed access
IPIsabella Prunner
Isabella Prunner
HPHarald Pothmann
Harald Pothmann
Karen WagenerKaren Wagener
Karen Wagener
MGMauricio Javier Giuliodori
Mauricio Javier Giuliodori
JHJohann Huber
Johann Huber
MDMarc Drillich
Marc Drillich

1 February 2015 in Veterinary Microbiology
Verified
Journal Article
Closed access
Karen WagenerKaren Wagener
Karen Wagener
IPI. Prunner
I. Prunner
HPH. Pothmann
H. Pothmann
MDM. Drillich
M. Drillich
Monika Ehling-SchulzMonika Ehling-Schulz
Monika Ehling-Schulz

1 May 2015 in Theriogenology
Verified
Journal Article
Closed access
HPH. Pothmann
H. Pothmann
IPI. Prunner
I. Prunner
Karen WagenerKaren Wagener
Karen Wagener
MJM. Jaureguiberry
M. Jaureguiberry
RSR.L. de la Sota
R.L. de la Sota
MDMarc Drillich
Marc Drillich

1 January 2021 in Theriogenology
Verified
Journal Article
Open access
PBPanagiotis Ballas
Panagiotis Ballas
URUlrike Reinländer
Ulrike Reinländer
RSRoland Schlegl
Roland Schlegl
MEMonika Ehling-Schulz
Monika Ehling-Schulz
MDMarc Drillich
Marc Drillich
Karen WagenerKaren Wagener
Karen Wagener
It is generally accepted that postpartum uterine infections decrease conception rates in dairy cows. Whereas clinical endometritis (CE) has been studied intensively, only little information about CE at the time of artificial insemination (AI) is available. The aim of this study was to characterize the intrauterine cultivable aerobic microbiota in healthy cows and in cows with mild CE at AI and to investigate its effect on the subsequent insemination success. The vaginal discharge score (VDS) of 120 Holstein Frisian dairy cows was assessed shortly after AI using the Metricheck device and pregnancy diagnosis was performed 39 days after AI. On average, cows received their second insemination (2.0 ± 1.2 standard deviation (SD)) and were 120.5 ± 40.2 days in milk. Intrauterine cytobrush samples were taken from cows with clear mucus (VDS 0, n = 58) and from cows with flecks of pus (VDS 1, n = 62), which was regarded as mild CE. Bacteria collected with the cytobrush were cultivated aerobically and identified by matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). A total of 358 bacterial isolates were recovered, comprising 49 bacterial genera and 116 species. Bacillus, Staphylococcus, Corynebacterium and Streptococcus were the most prevalent genera with relative abundances of 19.6%, 14.2%, 10.1% and 8.1%, whereas common uterine pathogens, such as Trueperella pyogenes and Escherichia coli, were rarely detected. Bacillus spp. were more frequently detected in group VDS 0 (51.7%) than in VDS 1 (22.6%; P = 0.001) and there was a higher prevalence of Corynebacterium spp. in VDS 0 than in VDS 1 (37.9% vs 19.3%; P = 0.03). Cows with VDS 1 at the time of AI harbored neither Bacillus licheniformis nor Bacillus subtilis, while these species were detected in 27.6% and 8.6% of VDS 0 (P < 0.001 and P = 0.024 respectively). The insemination success in VDS 0 and 1 was 43.1 and 25.8% (P = 0.046). The diagnosis of mild CE at AI and the total bacterial load decreased the chance of pregnancy (P = 0.03) but no significant correlation between a distinctive bacterial species and insemination success was observed. In summary, cultivable uterine bacteria at AI presumably represent a part of the physiological microbiota, which is not directly linked to impaired fertility. These findings question intrauterine antimicrobial treatment shortly after AI and could represent the basis for the development of future treatment strategies.